Pablo Cagnoni Insider Profile

4 Followers
Pablo Cagnoni, EVP, Global R&D and Tech Ops at Onyx Pharma, holds 0.00 shares in Onyx Pharma (Ticker: ONXX), holds 221.17K shares in Incyte (Ticker: INCY), holds 66.08K shares in Rubius Therapeutics (Ticker: RUBY). Most recently, Pablo Cagnoni ― shares of Onyx Pharma on ― for an estimated value of ―.
tipranks
Pablo Cagnoni

Pablo Cagnoni
Onyx Pharma (ONXX)
EVP, Global R&D and Tech Ops

Not Ranked
Pablo Cagnoni has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$18M
100.00%
0.00%
A breakdown of Pablo Cagnoni's holdings

Insider Roles

Incyte
(INCY)
President, R&D
Crispr Therapeutics AG
(CRSP)
Director
Roles that Pablo Cagnoni holds in companies

Most Profitable Insider Trade

Stock:
Rubius Therapeutics
(RUBY)
Rating:Informative Buy
Date:Apr 15, 2020 - Apr 15, 2021
Return:+436.80%
The most profitable trade made by Pablo Cagnoni

Pablo Cagnoni's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ONXX
Onyx Pharma
Crispr Therapeutics AG
Nov 21, 2019
Director
Uninformative Buy
41.92K
$0.00
RUBY
Rubius Therapeutics
Feb 01, 2023
Uninformative Sell
2.11K
$3.77K
FUSN
Fusion Pharmaceuticals
Incyte
Jul 17, 2024
President, R&D
Uninformative Buy
$17.82M
List of latest transactions for each holding click on a transaction to see Pablo Cagnoni's performance on stock

Pablo Cagnoni insider profile FAQ

What is the percentage of profitable transactions made by Pablo Cagnoni?
The percentage of profitable transactions made by Pablo Cagnoni is ―.
    What is the average return per transaction made by Pablo Cagnoni?
    The average return per transaction made by Pablo Cagnoni is ―.
      What stocks does Pablo Cagnoni hold?
      Pablo Cagnoni holds: ONXX, CRSP, RUBY, FUSN, INCY stocks.
        What was Pablo Cagnoni’s latest transaction?
        Pablo Cagnoni latest transaction was an Uninformative Buy of ―.
          What was Pablo Cagnoni's most profitable transaction?
          Pablo Cagnoni’s most profitable transaction was an Informative Buy of RUBY stock on April 15, 2020. The return on the trade was 436.80%.
            What is Pablo Cagnoni's role in Onyx Pharma?
            Pablo Cagnoni's role in Onyx Pharma is EVP, Global R&D and Tech Ops.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.